首页> 外文期刊>Bone marrow transplantation >Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease.
【24h】

Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease.

机译:慢性移植物抗宿主病期间表达外周血单核细胞的HLA-C特异性杀伤细胞抑制受体(CD158b)的顺序分析。

获取原文
获取原文并翻译 | 示例
       

摘要

We have sequentially investigated the expression of natural killer cell inhibitory receptors (KIRs) for HLA-C (CD158b) on peripheral blood mononuclear cells (PBMC) in three patients with extensive chronic graft-versus-host disease (cGVHD) after allogeneic bone marrow transplantation (alloBMT). Clinical symptoms of cGVHD were not cured and worsened in the first patient whose CD158b-positive cells increased to 18.5% during cGVHD and decreased to 9.4% at 8 months after transplantation. On the other hand, cGVHD was cured and did not relapse in the second patient whose CD158b-positive cells increased up to 45.9% during cGVHD and sustained 19.4% at 8 months after transplantation. In contrast, CD158b-positive cells were less than 10% during the course of cGVHD in the third patient, and her cGVHD did not respond to treatment. Therefore, it appears that chronic allostimulation augments the expansion of CD158b-positive cells and these expanded CD158b-positive cells may have some role in the control of alloresponse in some patients.
机译:我们已经依次研究了同种异体骨髓移植后三例广泛的慢性移植物抗宿主病(cGVHD)患者外周血单个核细胞(PBMC)中HLA-C(CD158b)的自然杀伤细胞抑制受体(KIRs)的表达(alloBMT)。首例患者的cGVHD的临床症状未能治愈并恶化,其CD158b阳性细胞在cGVHD期间升高至18.5%,在移植后8个月降低至9.4%。另一方面,第二例患者的cGVHD治愈且未复发,其CD158b阳性细胞在cGVHD期间增加至45.9%,在移植后8个月维持19.4%。相比之下,第三位患者在cGVHD过程中CD158b阳性细胞少于10%,她的cGVHD对治疗无反应。因此,似乎慢性同种异体刺激增加了CD158b阳性细胞的扩增,并且这些扩增的CD158b阳性细胞可能在某些患者的过敏反应控制中具有一定作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号